United States · FDA National Drug Code directory
FILSPARI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68974-400_2299f93e-22fc-48ac-8d06-c558fc57bb0d
- Product NDC
- 68974-400
- Form
- TABLET, FILM COATED
- Composition / generic term
- sparsentan
- Labeler
- Travere Therapeutics, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230217
- Source listing expiry
- 20271231
Source-listed ingredients
- SPARSENTAN — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (68974-400-30) · 68974-400-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →